IBAC:NASDAQIB Acquisition Corp. Analysis
Data as of 2026-05-23 - not real-time
$10.79
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
IB Acquisition Corp. (IBAC) is trading at $10.79, essentially flat on the day and hugging its 20‑day and 50‑day SMAs (10.80 and 10.77). The technical picture shows a bullish trend direction and a clear support zone at $10.72, but the MACD is bearish (histogram –0.007) and RSI sits at a neutral 51, limiting upside to the nearby resistance of $10.84.
Fundamentally, the stock is dramatically overvalued: a DCF fair‑value estimate of $0.18, a negative book‑value per share (‑$0.15) and a price‑to‑book ratio of –71.9 underscore the disconnect. The company has zero revenue, negative cash flow and a trailing EPS of –$0.01, confirming its shell‑company status. The recent news of a planned business combination with GNQ Insilico Inc. could act as a catalyst, but it also adds execution risk. Overall, the combination of an extreme valuation premium, weak fundamentals, and modest technical support suggests caution.
Fundamentally, the stock is dramatically overvalued: a DCF fair‑value estimate of $0.18, a negative book‑value per share (‑$0.15) and a price‑to‑book ratio of –71.9 underscore the disconnect. The company has zero revenue, negative cash flow and a trailing EPS of –$0.01, confirming its shell‑company status. The recent news of a planned business combination with GNQ Insilico Inc. could act as a catalyst, but it also adds execution risk. Overall, the combination of an extreme valuation premium, weak fundamentals, and modest technical support suggests caution.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- MACD bearish signal despite bullish trend direction
- Price trades at a massive premium to DCF fair value ($10.79 vs $0.18)
- Uncertainty surrounding the upcoming SPAC merger
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside if the merger with GNQ Insilico gains approval
- Technical support at $10.72 provides a short‑term floor
- Very low beta (≈0.006) limits broader market volatility exposure
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Persistent lack of operating revenue and negative cash flow
- Continued valuation gap with no underlying earnings
- Shell‑company risk and negative book value remain unresolved
Key Metrics & Analysis
Financial Health
ROE6619.30%
ROA-0.69%
P/B Ratio-71.9
Op. Cash Flow$-1993446
Free Cash Flow$57.1K
Industry P/E16.8
Technical Analysis
TrendBullish
RSI51.3
Support$10.72
Resistance$10.84
MA 20$10.80
MA 50$10.77
MA 200$10.59
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
Fair Value$0.18
GradeOvervalued
TypeValue
Risk Assessment
Beta0.01
Volatility3.88%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.